Sastasundar Ventures Limited (SASTASUNDR.BO)
INR 265.35
(2.06%)
INR 265.35
(2.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -229.64 Million INR | 162.27% |
| 2022 | -595.02 Million INR | -12.72% |
| 2021 | -527.85 Million INR | -168.17% |
| 2020 | -196.83 Million INR | 65.62% |
| 2019 | -572.54 Million INR | -37.41% |
| 2018 | -416.67 Million INR | -101.92% |
| 2017 | -206.35 Million INR | 28.69% |
| 2016 | -289.37 Million INR | 22.68% |
| 2015 | -374.23 Million INR | -133.44% |
| 2014 | -160.31 Million INR | -102.25% |
| 2013 | -79.26 Million INR | -164.14% |
| 2012 | 123.58 Million INR | -44.37% |
| 2011 | 222.14 Million INR | -46.62% |
| 2010 | 416.15 Million INR | -53.25% |
| 2009 | 890.09 Million INR | 85.52% |
| 2008 | 479.78 Million INR | -24.59% |
| 2007 | 636.23 Million INR | 132.61% |
| 2006 | 273.51 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -111.1 Million INR | -152.42% |
| 2023 Q1 | 15.47 Million INR | 110.16% |
| 2023 Q2 | 39.44 Million INR | 154.89% |
| 2023 Q4 | -44.01 Million INR | 26.49% |
| 2023 Q3 | -59.88 Million INR | -251.81% |
| 2023 FY | 370.49 Million INR | 162.27% |
| 2022 Q2 | -117.61 Million INR | 14.07% |
| 2022 FY | -595.02 Million INR | -12.72% |
| 2022 Q4 | -152.28 Million INR | -21.92% |
| 2022 Q3 | -124.91 Million INR | -6.2% |
| 2022 Q1 | -136.87 Million INR | 28.12% |
| 2021 Q3 | -138.16 Million INR | -12.51% |
| 2021 Q2 | -122.8 Million INR | -32.02% |
| 2021 Q1 | -93.01 Million INR | -53.57% |
| 2021 FY | -527.85 Million INR | -168.17% |
| 2021 Q4 | -190.4 Million INR | -37.81% |
| 2020 Q3 | -51.14 Million INR | -24.28% |
| 2020 Q4 | -60.57 Million INR | -18.43% |
| 2020 Q1 | -19.86 Million INR | 85.15% |
| 2020 FY | -196.83 Million INR | 65.62% |
| 2020 Q2 | -41.15 Million INR | -107.21% |
| 2019 Q2 | -138.43 Million INR | 10.78% |
| 2019 FY | -572.54 Million INR | -37.41% |
| 2019 Q4 | -133.73 Million INR | -3.56% |
| 2019 Q1 | -155.16 Million INR | 14.22% |
| 2019 Q3 | -129.14 Million INR | 6.71% |
| 2018 FY | -416.67 Million INR | -101.92% |
| 2018 Q4 | -180.89 Million INR | -94.92% |
| 2018 Q3 | -92.8 Million INR | -27.37% |
| 2018 Q2 | -72.86 Million INR | -13.75% |
| 2018 Q1 | -64.05 Million INR | -6.79% |
| 2017 Q3 | 33.9 Million INR | 191.63% |
| 2017 Q2 | -36.99 Million INR | 48.47% |
| 2017 Q1 | -71.8 Million INR | -4.38% |
| 2017 Q4 | -59.98 Million INR | -276.94% |
| 2017 FY | -206.35 Million INR | 28.69% |
| 2016 Q1 | -83.38 Million INR | 34.73% |
| 2016 FY | -289.37 Million INR | 22.68% |
| 2016 Q4 | -68.79 Million INR | 10.42% |
| 2016 Q3 | -76.79 Million INR | -51.87% |
| 2016 Q2 | -50.56 Million INR | 39.36% |
| 2015 Q3 | -95.58 Million INR | -8.97% |
| 2015 Q1 | -57.28 Million INR | 32.43% |
| 2015 Q2 | -87.71 Million INR | -53.12% |
| 2015 Q4 | -127.75 Million INR | -33.65% |
| 2015 FY | -374.23 Million INR | -133.44% |
| 2014 Q4 | -84.77 Million INR | -249.88% |
| 2014 Q3 | -24.23 Million INR | 7.06% |
| 2014 Q1 | -23.63 Million INR | 45.94% |
| 2014 Q2 | -26.07 Million INR | -10.29% |
| 2014 FY | -160.31 Million INR | -102.25% |
| 2013 Q2 | -5.87 Million INR | 57.26% |
| 2013 FY | -79.26 Million INR | -164.14% |
| 2013 Q3 | -15.92 Million INR | -171.11% |
| 2013 Q1 | -13.74 Million INR | 96.41% |
| 2013 Q4 | -43.72 Million INR | -174.57% |
| 2012 Q3 | 32.2 Million INR | -40.35% |
| 2012 Q2 | 53.99 Million INR | 15.34% |
| 2012 Q1 | 46.81 Million INR | 0.0% |
| 2012 FY | 123.58 Million INR | -44.37% |
| 2012 Q4 | -383.25 Million INR | -1289.98% |
| 2011 Q1 | - INR | 0.0% |
| 2011 FY | 222.14 Million INR | -46.62% |
| 2011 Q2 | - INR | 0.0% |
| 2010 FY | 416.15 Million INR | -53.25% |
| 2009 FY | 890.09 Million INR | 85.52% |
| 2008 FY | 479.78 Million INR | -24.59% |
| 2007 FY | 636.23 Million INR | 132.61% |
| 2006 FY | 273.51 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 53.74 Million INR | 527.332% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 126.892% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | 2982.129% |
| MedPlus Health Services Limited | 1.31 Billion INR | 117.401% |
| ANG Lifesciences India Limited | 12.8 Million INR | 1893.424% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 396.049% |
| Bacil Pharma Limited | -1.89 Million INR | -12022.85% |
| BDH Industries Limited | 169.01 Million INR | 235.874% |
| Beryl Drugs Limited | 14.73 Million INR | 1658.838% |
| Cian Healthcare Limited | 53.96 Million INR | 525.518% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 1497.311% |
| Concord Drugs Limited | 24.87 Million INR | 1023.319% |
| Deccan Health Care Limited | 185.32 Million INR | 223.914% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | 2654.483% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | 43283.152% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 134.325% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | -508.226% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 145.865% |
| Makers Laboratories Limited | -34.91 Million INR | -557.829% |
| Medi-Caps Limited | -17.21 Million INR | -1234.387% |
| Panchsheel Organics Limited | 288.28 Million INR | 179.659% |
| Parmax Pharma Limited | 3.75 Million INR | 6216.525% |
| Parnax Lab Limited | 166.84 Million INR | 237.642% |
| Patidar Buildcon Limited | -1.83 Million INR | -12408.061% |
| Phaarmasia Limited | - INR | Infinity% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 167.651% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 456.205% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -56463.547% |
| Smruthi Organics Limited | - INR | Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 772.37% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 206.477% |
| Trident Lifeline Limited | 72.21 Million INR | 418.024% |
| Transchem Limited | -17.43 Million INR | -1216.864% |
| Trinity League India Limited | 1.17 Million INR | 19677.835% |
| Tyche Industries Limited | 111.22 Million INR | 306.475% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | -2163.211% |
| Vivanza Biosciences Limited | 14.83 Million INR | 1648.328% |
| PRAVEG LIMITED | 185.06 Million INR | 224.088% |
| Sunil Healthcare Limited | -19.98 Million INR | -1049.332% |
| Syschem (India) Limited | 504.91 Million INR | 145.482% |
| Zenith Healthcare Limited | 196 Thousand INR | 117267.347% |
| Zenlabs Ethica Limited | 89.27 Million INR | 357.231% |
| Mercury Laboratories Limited | 62.14 Million INR | 469.518% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 332.742% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 474.776% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | -43.464% |
| Roopa Industries Limited | 48.05 Million INR | 577.866% |
| PANJON LTD. | - INR | Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | -53.804% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | -1181.732% |
| Anuh Pharma Limited | 682.19 Million INR | 133.663% |
| Crestchem Limited | 27.25 Million INR | 942.563% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | -1853.62% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 1441.01% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 163.046% |
| Trimurthi Limited | -6.14 Million INR | -3638.345% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 197.201% |
| Norris Medicines Limited | 11.15 Million INR | 2158.3% |
| Veerhealth Care Limited | 34.19 Million INR | 771.642% |
| Lactose (India) Limited | 137.78 Million INR | 266.67% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | -85.841% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 152.574% |
| Gennex Laboratories Limited | 146.61 Million INR | 256.63% |
| Denis Chem Lab Limited | 142.87 Million INR | 260.731% |
| Colinz Laboratories Limited | 14.64 Million INR | 1668.313% |
| Godavari Drugs Limited | -67.67 Million INR | -239.36% |
| Zenotech Laboratories Limited | 242.37 Million INR | 194.749% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 140.114% |
| Bharat Parenterals Limited | 733.49 Million INR | 131.309% |
| Coral Laboratories Limited | 142.63 Million INR | 261.006% |
| Evoq Remedies Limited | 42.91 Million INR | 635.098% |
| Kerala Ayurveda Limited | 48.04 Million INR | 577.975% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | -9160.0% |
| Natural Capsules Limited | 112.4 Million INR | 304.313% |
| Auro Laboratories Limited | 95.77 Million INR | 339.779% |